AstraZeneca plans to increase investment and scope of its Virginia manufacturing facility to $4.5 billion, creating 3,600 new jobs
BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand